関連する実験動画

Updated: May 19, 2026

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization

Published on: January 17, 2020

人間の誘発性多能性幹細胞による上弁性大動脈狭窄症候群のモデル化

Xin Ge¹, Yongming Ren, Oscar Bartulos

¹YCVRC Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, Yale Stem Cell Center, Ste 773A, 300 George St, New Haven, CT 06510, USA.

|August 24, 2012

まとめ

超弁膜性大動脈狭窄症 (SVAS) の患者の細胞は,異常な滑らかな筋肉細胞の増殖と移動を示します. これらの患者特有の誘発性多能幹細胞 (iPSC-SMCs) による滑らかな筋肉細胞は,SVASを研究し,治療法を開発するためのモデルを提供します.

科学分野:

心血管生物学心血管生物学
幹細胞生物学幹細胞生物学
遺伝学遺伝学とは

背景:

超弁膜性大動脈狭窄症 (SVAS) は,エラスティン (ELN) 遺伝子変異の結果であり,血管の滑らかな筋肉細胞 (SMC) の過剰成長と動脈狭窄を引き起こします.
患者特有のSMCは,SVASの病原性を理解し,治療法を開発するために不可欠です.

研究の目的:

SVAS患者のヒト誘発性多能幹細胞 (iPSC) ラインを開発し,特徴づけること.
患者から派生したiPSC-SMCを使用して,SVASの基礎となる細胞および分子メカニズムを調査する.

主な方法:

ELN遺伝子変異を有するSVAS患者から生成されたiPSCライン.
iPSCをSMC (iPSC-SMC) に区分し,SVAS iPSC-SMCを対照群と比較した.
評価されたSMCの分化,増殖,移動,シグナル伝達経路 (RhoA,ERK1/2).

主要な成果:

SVAS iPSC-SMCは,対照群と比較して,組織化された滑らかな筋肉α-アクチンフィラメント束が少ないことを示した.
SVAS iPSC-SMCは,著しく高い拡散と移住率を示しました.
エラスティンタンパク質またはRhoAシグナリング強化は,部分的にフィラメント形成を救出しました. ERK1/2の活性が上昇すると,過剰増殖と関連していました.

結論:

SVAS iPSC-SMCは,疾患の主要な病理学的特徴を正確にモデル化しています.
このiPSC-SMCモデルは,SVASのメカニズムと治療の開発を研究するための貴重なプラットフォームを提供します.

さらに関連する動画

A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids

A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids

Published on: March 17, 2026

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Published on: March 10, 2023

関連する概念動画

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...